First-in-human clinical series of a novel conformable large-lattice pulsed field ablation catheter for pulmonary vein isolation
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem, klinické zkoušky
Grantová podpora
Affera, Inc
PubMed
38584468
PubMed Central
PMC11057205
DOI
10.1093/europace/euae090
PII: 7641959
Knihovny.cz E-zdroje
- Klíčová slova
- Atrial fibrillation, Catheter ablation, Electroanatomical mapping system, Lesion durability, Pulsed field ablation, Single-shot,
- MeSH
- akční potenciály MeSH
- časové faktory MeSH
- design vybavení MeSH
- elektrofyziologické techniky kardiologické MeSH
- fibrilace síní * chirurgie patofyziologie diagnóza MeSH
- katetrizační ablace * metody přístrojové vybavení MeSH
- lidé středního věku MeSH
- lidé MeSH
- recidiva * MeSH
- senioři MeSH
- srdeční frekvence MeSH
- srdeční katétry * MeSH
- venae pulmonales * chirurgie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
AIMS: Pulsed field ablation (PFA) has significant advantages over conventional thermal ablation of atrial fibrillation (AF). This first-in-human, single-arm trial to treat paroxysmal AF (PAF) assessed the efficiency, safety, pulmonary vein isolation (PVI) durability and one-year clinical effectiveness of an 8 Fr, large-lattice, conformable single-shot PFA catheter together with a dedicated electroanatomical mapping system. METHODS AND RESULTS: After rendering the PV anatomy, the PFA catheter delivered monopolar, biphasic pulse trains (5-6 s per application; ∼4 applications per PV). Three waveforms were tested: PULSE1, PULSE2, and PULSE3. Follow-up included ECGs, Holters at 6 and 12 months, and symptomatic and scheduled transtelephonic monitoring. The primary and secondary efficacy endpoints were acute PVI and post-blanking atrial arrhythmia recurrence, respectively. Invasive remapping was conducted ∼75 days post-ablation. At three centres, PVI was performed by five operators in 85 patients using PULSE1 (n = 30), PULSE2 (n = 20), and PULSE3 (n = 35). Acute PVI was achieved in 100% of PVs using 3.9 ± 1.4 PFA applications per PV. Overall procedure, transpired ablation, PFA catheter dwell and fluoroscopy times were 56.5 ± 21.6, 10.0 ± 6.0, 19.1 ± 9.3, and 5.7 ± 3.9 min, respectively. No pre-defined primary safety events occurred. Upon remapping, PVI durability was 90% and 99% on a per-vein basis for the total and PULSE3 cohort, respectively. The Kaplan-Meier estimate of one-year freedom from atrial arrhythmias was 81.8% (95% CI 70.2-89.2%) for the total, and 100% (95% CI 80.6-100%) for the PULSE3 cohort. CONCLUSION: Pulmonary vein isolation (PVI) utilizing a conformable single-shot PFA catheter to treat PAF was efficient, safe, and effective, with durable lesions demonstrated upon remapping.
Department of Biomedicine and Prevention Division of Cardiology University of Tor Vergata Rome Italy
Department of Cardiology Homolka Hospital Prague Czech Republic
Department of Cardiology Institute for Clinical and Experimental Medicine IKEM Prague Czech Republic
Department of Cardiology Vilnius University Vilnius Lithuania
Division of Cardiovascular Medicine Shamir Medical Center Be'er Yaakov Tel Aviv Israel
Texas Cardiac Arrhythmia Institute St David's Medical Center Austin TX USA
Zobrazit více v PubMed
Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EMet al. . 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines. J Am Coll Cardiol 2024;83:109–279. PubMed PMC
Howard B, Haines DE, Verma A, Kirchhof N, Barka N, Onal Bet al. . Characterization of phrenic nerve response to pulsed field ablation. Circ Arrhythm Electrophysiol 2022;15:e010127. PubMed PMC
Neven K, van Es R, van Driel V, van Wessel H, Fidder H, Vink Aet al. . Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus. Circ Arrhythm Electrophysiol 2017;10:e004672. PubMed
Koruth JS, Kuroki K, Iwasawa J, Enomoto Y, Viswanathan R, Brose Ret al. . Preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation. Circ Arrhythm Electrophysiol 2019;12:e007781. PubMed PMC
Koruth JS, Kuroki K, Kawamura I, Brose R, Viswanathan R, Buck EDet al. . Pulsed field ablation vs radiofrequency ablation: esophageal injury in a novel porcine model. Circ Arrhythm Electrophysiol 2020;13:e008303. PubMed PMC
Koruth JS, Kuroki J, Kawamura I, Stoffregen WC, Dukkipati SR, Neuzil Pet al. . Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions: a preclinical assessment of safety and durability. Circ Arrhythm Electrophysiol 2020;13:e008716. PubMed
Howard B, Haines DE, Verma A, Packer D, Kirchhof N, Barka Net al. . Reduction in pulmonary vein stenosis and collateral damage with pulsed field ablation compared with radiofrequency ablation in a canine model. Circ Arrhythm Electrophysiol 2020;13:e008337. PubMed PMC
Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet Het al. . Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 2019;74:315–26. PubMed
Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako Met al. . Pulsed field ablation of paroxysmal atrial fibrillation: one-year outcomes of IMPULSE, PEFCAT & PEFCAT II. JACC Clin Electrophysiol 2021;7:614–27. PubMed
Reddy VY, Anic A, Koruth J, Petru J, Funasako M, Minami Ket al. . Pulsed field ablation in patients with persistent atrial fibrillation. J Am Coll Cardiol 2020;76:1068–80. PubMed
Reddy VY, Peichl P, Anter E, Rackauskas G, Petru J, Funasako Met al. . A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol 2023;9:1786–801. PubMed
Cochet H, Nakatani Y, Sridi-Cheniti S, Cheniti G, Ramirez FD, Nakashima Tet al. . Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. Europace 2021;23:1391–9. PubMed PMC
Kuroki K, Whang W, Eggert C, Lam J, Leavitt J, Kawamura Iet al. . Ostial dimensional changes after pulmonary vein isolation: pulsed field ablation vs radiofrequency ablation. Heart Rhythm 2020;17:1528–35. PubMed
Mansour M, Gerstenfeld EP, Patel C, Natale A, Whang W, Cuoco FAet al. . Pulmonary vein narrowing after pulsed field versus thermal ablation. Europace 2024;26:euae038. PubMed PMC
Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner Aet al. . Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace 2022;24:1256–66. PubMed PMC
Turagam MK, Neuzil P, Petru J, Funasako M, Koruth JS, Reinders Det al. . PV isolation using a spherical array PFA catheter: application repetition and lesion durability (PULSE-EU study). JACC Clin Electrophysiol 2023;9:638–48. PubMed
Serban T, Mannhart D, Abid Q-U-A, Höchli A, Lazar S, Krisai Pet al. . Durability of pulmonary vein isolation for atrial fibrillation: a meta-analysis and systematic review. Europace 2023;25:euad335. PubMed PMC
Verma A, Haines DE, Boersma LV, Sood N, Natale A, Marchlinski FEet al. . Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation 2023;147:1422–32. PubMed PMC
Duytschaever M, De Potter E, Grimaldi M, Anic A, Vijgen J, Neuzil Pet al. . Paroxysmal AF ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3d mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol 2023;16:e011780. PubMed PMC
Reddy VY, Gerstenfeld EP, Natale A, Whang W, Cuoco FA, Patel Cet al. . Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med 2023;389:1660–71. PubMed
Tohoku S, Chun KRJ, Bordignon S, Chen S, Schaack D, Urbanek Let al. . Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation. Europace 2023;25:433–40. PubMed PMC
Turagam MK, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner Aet al. . Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry. Circulation 2023;148:35–46. PubMed
Kueffer T, Bordignon S, Neven K, Blaauw Y, Hansen J, Adelino R, et al. . Durability of pulmonary vein isolation using pulsed-field ablation: results from the multicenter EU-PORIA registry. JACC Clin Electrophysiol 2024:S2405-500X(23)00917-9. Online ahead of print. PubMed
Schmidt B, Bordignon S, Neven K, Reichlin T, Blaauw Y, Hansen Jet al. . EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace 2023;25:euad185. PubMed PMC
Koruth J, Kawamura I, Dukkipati SR, Neuzil P, Reddy VY. Preclinical assessment of the feasibility, safety and lesion durability of a novel ‘single-shot’ pulsed field ablation catheter for pulmonary vein isolation. Europace 2023;25:1369–78. PubMed PMC
Yavin HD, Higuchi K, Younis A, Anter E. Lattice-tip catheter for single-shot pulmonary vein isolation with pulsed field ablation. J Interv Card Electrophysiol 2023;66:1741–8. PubMed
Yavin H, Shapira-Daniels A, Barkagan M, Sroubek J, Shim D, Melidone Ret al. . Pulsed field ablation using a lattice electrode for focal energy delivery: biophysical characterization, lesion durability, and safety evaluation. Circ Arrhythm Electrophysiol 2020;13:e008580. PubMed PMC
Deneke T, Jais P, Scaglione M, Schmitt R, DI Biase L, Christopoulos Get al. . Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol 2015;26:455–63. PubMed
Calvert P, Kollias G, Pürerfellner H, Narasimhan C, Osorio J, Lip GYHet al. . Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review. Europace 2023;25:euad151. PubMed PMC
Haeusler KG, Eichner FA, Heuschmann PU, Fiebach JB, Engelhorn T, Callans Det al. . Detection of brain lesions after catheter ablation depends on imaging criteria: insights from AXAFA-AFNET 5 trial. Europace 2023;25:euad323. PubMed PMC
Haeusler KG, Eichner FA, Heuschmann PU, Fiebach JB, Engelhorn T, Blank Bet al. . MRI-detected brain lesions and cognitive function in patients with atrial fibrillation undergoing left atrial catheter ablation in the randomized AXAFA-AFNET 5 trial. Circulation 2022;145:906–15. PubMed
Howard B, Verma A, Tzou WS, Mattison L, Kos B, Miklavčič Det al. . Effects of electrode-tissue proximity on cardiac lesion formation using pulsed field ablation. Circ Arrhythm Electrophysiol 2022;15:e011110. PubMed PMC
Mattison L, Verma A, Tarakji KG, Reichlin T, Hindricks G, Sack KLet al. . Effect of contact force on pulsed field ablation lesions in porcine cardiac tissue. J Cardiovasc Electrophysiol 2023;34:693–9. PubMed
Di Biase L, Marazzato J, Govari A, Altman A, Beeckler C, Keyes Jet al. . Pulsed field ablation index–guided ablation for lesion formation: impact of contact force and number of applications in the ventricular model. Circ Arrhythm Electrophysiol 2024;17:e012717. PubMed PMC
Stojadinović P, Wichterle D, Peichl P, Nakagawa H, Čihák R, Hašková Jet al. . Autonomic changes are more durable after radiofrequency than pulsed electric field pulmonary vein ablation. JACC Clin Electrophysiol 2022;8:895–904. PubMed
Musikantow DR, Neuzil P, Petru J, Koruth JS, Kralovec S, Miller MAet al. . Pulsed field ablation to treat atrial fibrillation: autonomic nervous system effects. JACC Clin Electrophysiol 2023;9:481–93. PubMed
Tohoku S, Schmidt B, Schaack D, Bordignon S, Hirokami J, Chen Set al. . Impact of pulsed-field ablation on intrinsic cardiac autonomic nervous system after pulmonary vein isolation. JACC Clin Electrophysiol 2023;9:1864–75. PubMed
Del Monte A, Cespón Fernández M, Vetta G, Della Rocca DG, Pannone L, Mouram Set al. . Quantitative assessment of transient autonomic modulation after single-shot pulmonary vein isolation with pulsed-field ablation. J Cardiovasc Electrophysiol 2023;34:2393–7. PubMed
Katritsis DG, Pokushalov E, Romanov A, Giazitzoglou E, Siontis GCM, Po SSet al. . Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol 2013;62:2318–25. PubMed
Reddy VY, Ekanem E. Multi-national survey on the safety of the post-approval clinical use of pulsed field ablation in 17,000+ patients (MANIFEST-17K). American Heart Association Annual Scientific Sessions 2023. (Presented Nov. 11, 2023 in Philadelphia, PA).
Venier S, Vaxelaire N, Jacon P, Carabelli A, Desbiolles A, Garban Fet al. . Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation. Europace 2023;26:euad371. PubMed PMC
Metzner A, Fiala M, Vijgen J, Ouss A, Gunawardene M, Hansen Jet al. . Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom study. Europace 2024;26:euae053. PubMed PMC